On June 5, 2025, Aytu BioPharma, Inc. entered into an underwriting agreement for a public offering of 1,366,668 shares at $1.50 each and 8,233,332 prefunded warrants at $1.4999 each, expecting to raise approximately $12.9 million for corporate purposes. The offering is expected to close on or about June 9, 2025.